文献速递神经介入外周血管DSA

经肱动脉与经桡动脉作为大孔径神经支架置入中经股动脉入路的替代方案比较:一项倾向性匹配研究的启示

Comparing Transbrachial and Transradial as Alternatives to Transfemoral Access for Large-Bore Neuro Stenting: Insights From a Propensity-Matched Study.
PubMed 文献 · Acad Radiol · 2024-07-10

本研究比较经肱动脉(TBA)、经桡动脉(TRA)与经股动脉(TFA)在大孔径(≥7 F)神经支架置入中的安全性和有效性。倾向性匹配后纳入46例TBA、46例TRA和92例TFA患者,技术成功率和显著入路部位并发症率组间相当(P>0.05)。与TFA相比,TRA组在到达导管室至穿刺时间、穿刺至造影完成时间及手术时长上均显著延迟,而TBA与TFA在手术时间指标上无显著差异。作者认为TBA和TRA作为大孔径神经支架置入的首选入路安全有效,TRA的手术延迟可能使TBA成为TFA的首选替代入路。

要点

  • 大孔径(≥7 F)神经支架置入中,TBA、TRA与TFA的技术成功率和显著入路部位并发症率组间相当(P>0.05)。
  • 与TFA相比,TRA组到达导管室至穿刺时间、穿刺至造影完成时间及手术时长均显著延迟。
  • TBA与TFA在手术时间指标上无显著差异,TRA的手术延迟可能使TBA成为TFA的首选替代入路。

核心结论

  • TBA和TRA作为大孔径神经支架置入的首选入路安全有效;TRA的手术延迟可能使TBA成为TFA的首选替代入路。

研究设计与样本

  • 本研究为倾向性匹配研究,2019年1月至2024年1月在本中心接受大孔径(≥7 F)神经支架置入的4752例患者中,按1:1:2比例(TBA:TRA:TFA)进行倾向性评分匹配,调整年龄、性别、主动脉弓类型和神经支架置入作为协变量,最终纳入46例TBA、46例TRA和92例TFA患者。

诊断标准与关键数值

  • 技术成功率:TBA 100%,TRA 95.7%,TFA 100%,组间比较P>0.05。
  • 显著入路部位并发症率(包括明显血肿、假性动脉瘤、动脉闭塞及需治疗(药物、介入或手术)的并发症):TBA 4.3%,TRA 6.5%,TFA 1.1%,组间比较P>0.05。
  • 与TFA相比,TRA组到达导管室至穿刺时间14 vs. 8 min(P=0.039)、穿刺至造影完成时间19 vs. 11 min(P=0.027)、手术时长42 vs. 29 min(P=0.031)均显著延迟。
  • TBA组对应时间指标分别为10、14、31 min,与TFA相比无显著差异。

临床应用与阅片要点

  • 在大孔径(≥7 F)神经支架置入中,TBA和TRA可作为TFA的替代入路,技术成功率和显著入路部位并发症率与TFA相当。
  • 与TFA相比,TRA在到达导管室至穿刺时间、穿刺至造影完成时间及手术时长上显著延迟,而TBA与TFA在手术时间指标上无显著差异。
  • 作者认为,TRA的手术延迟可能使TBA成为TFA的首选替代入路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to evaluate the safety and effectiveness of transbrachial access (TBA) and transradial access (TRA) compared to transfemoral access (TFA) for large-bore neuro stenting (≥7 F).

METHODS: From January 2019 to January 2024, 4752 patients received large-bore neuro stenting in our center. The primary outcomes were procedural metrics. Safety outcomes were significant access site complications, including substantial hematoma, pseudoaneurysm, artery occlusion, and complications requiring treatment (medicine, intervention, or surgery). After propensity score matching with a ratio of 1:1:2 (TBA: TRA: TFA), adjusting for age, gender, aortic arch type, and neuro stenting as covariates, outcomes were compared between groups.

RESULTS: 46 TBA, 46 TRA and 92 TFA patients were enrolled. The mean age was 67.8 ± 11.2 years, comprising 127 (69.0%) carotid artery stenting and 57 (31.0%) vertebral artery stenting. The rates of technical success (TBA: 100%, TRA: 95.7%, TFA: 100%) and significant access site complications (TBA: 4.3%, TRA: 6.5%, TFA: 1.1%) were comparable between the groups (P > 0.05). Compared to TFA, the TRA cohort exhibited significant delays in angiosuite arrival to puncture time (14 vs. 8 min, P = 0.039), puncture to angiography completion time (19 vs. 11 min, P = 0.027), and procedural duration (42 vs. 29 min, P = 0.031). There were no substantial differences in procedural time metrics between TBA (10, 14, and 31 min, respectively) and TFA.

CONCLUSION: TBA and TRA as the primary access for large-bore neuro stenting are safe and effective. Procedural delays in TRA may favor TBA as the first-line alternative access to TFA.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Qiu K, Liu X, Jia Z, et al. Comparing Transbrachial and Transradial as Alternatives to Transfemoral Access for Large-Bore Neuro Stenting: Insights From a Propensity-Matched Study. Acad Radiol. 2024. PMID: 38991867. doi:10.1016/j.acra.2024.06.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。